drugset

drugset / Trial / NCT05234762

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

NCT05234762 ↗

Phase 2 Unknown 24 enrolled ES Therapeutics Australia Pty Ltd

RandomizedCrossoverDouble-blindTreatment

Summary

This Pilot Phase 2A study will investigate the safety, tolerability, and pharmacokinetics (PK) of ES-481 in adult patients with essential tremor.

Timeline

Start: 2021-11-21
Primary completion: 2023-12-31
Completion: 2023-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ES-481	Unknown	75 mg	—

Indications